Centro Studi GISED

Centro Studi GISED was established in 2002 as a nonprofit organisation to develop independent clinical research in Dermatology and to promote an Evidence Based approach to the clinical management of skin disorders . Initially, activities were mainly focused on the coordination of the research projects of the Italian Group for Epidemiologic Research in Dermatology (GISED). Subsequently, they expanded to embrace any kind of clinical research, medical humanities, and health education.

In 2003, Centro Studi GISED got formal recognition for its activity and mandate by Regione Lombardia being entered in the Enterprise Registry (Registro delle Imprese) of the Bergamo Chamber of Commerce with number 2096.

In October 2003, Centro Studi GISED signed an agreement with the Regional Hospital, Ospedali Riuniti di Bergamo, and established its headquarter at the Department of Dermatology of the same Hospital.

Since 2003, following an agreement with the University of Milan, Centro Studi GISED is participating in the Inter-universitary Centre Thomas Chalmers for the development of systematic reviews and their implementation in clinical practice.

Dermatology category: Lymphomatoid papulosis

Question: I have a 15 year old daughter. From the age of 10 3 biopsies have been carried out and a diagnosis of “lymphomatoid papulosis” was made. The papules appeared at different sites on her body: thighs, chest, shoulders, chin and cheeks. They reappear about every 2 or 3 months but in recent years have been appearing more frequently...

Answer: Dear Writer, Thank you for the message I’m sorry for the late response. Lymphomatoid papulosis is a rather rare disease, more frequently seen in adults (majority of cases seem to occur between the ages of 30 and 40). In children only a limited number of cases have been described. It’s a recurrent cutaneous disease, clinically benign. Every single episode has a duration...

[Continue]

Psonet

Centro Studi GISED has recently established Psonet, an international register of systematic treatments for psoriasis in Europe, with the aim of obtaining safety and effectiveness data. A special focus is on the so-called "biologicals"...
[Continue]